Page last updated: 2024-10-24

cadralazine and Lupus Erythematosus, Systemic

cadralazine has been researched along with Lupus Erythematosus, Systemic in 3 studies

cadralazine: structure given in first source

Lupus Erythematosus, Systemic: A chronic, relapsing, inflammatory, and often febrile multisystemic disorder of connective tissue, characterized principally by involvement of the skin, joints, kidneys, and serosal membranes. It is of unknown etiology, but is thought to represent a failure of the regulatory mechanisms of the autoimmune system. The disease is marked by a wide range of system dysfunctions, an elevated erythrocyte sedimentation rate, and the formation of LE cells in the blood or bone marrow.

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19902 (66.67)18.7374
1990's1 (33.33)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Mulder, H1
PĂ„lsson, L1
Weiner, L1
Englund, G1
Henning, M1
Andersson, OK1

Other Studies

3 other studies available for cadralazine and Lupus Erythematosus, Systemic

ArticleYear
Conversion of drug-induced SLE-syndrome by the vasodilating agent cadralazine.
    European journal of clinical pharmacology, 1990, Volume: 38, Issue:3

    Topics: Adult; Blood Pressure; Humans; Hydralazine; Hypertension; Lupus Erythematosus, Systemic; Male; Pyrid

1990
Cadralazine challenge in patients with previous hydralazine-induced lupus: a 6-month study.
    Clinical pharmacology and therapeutics, 1989, Volume: 46, Issue:2

    Topics: Acetylation; Adult; Aged; Antihypertensive Agents; Blood Pressure; Female; Humans; Hydralazine; Lupu

1989
Cadralazine did not produce the SLE-syndrome when hydralazine did.
    European journal of clinical pharmacology, 1987, Volume: 31, Issue:6

    Topics: Adult; Humans; Hydralazine; Lupus Erythematosus, Systemic; Male; Pyridazines

1987